quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:50:51·23d
SECFiling
Imunon Inc. logo

SEC Form 10-K filed by Imunon Inc.

IMNN· Imunon Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • IMNN
    Imunon Inc.
    Health Care

Related

  • SEC23d
    Imunon Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR23d
    IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study
  • PR29d
    IMUNON Reports Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival with IMNN-001 in Women with Newly Diagnosed Advanced Ovarian Cancer
  • PR30d
    IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
  • SEC31d
    Imunon Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC31d
    SEC Form 424B5 filed by Imunon Inc.
  • SEC77d
    Imunon Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR77d
    IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022